$74 billion ~ Piece of C🎂KE for Bristol-Myers Squibb bmsnews $5.6 billion ~ All🔥 hell 🔥breaks loose
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Bristol-Myers Squibb buying Celgene in $74B dealBristol-Myers Squibb is spending $74 billion on fellow drugmaker Celgene in a deal aimed at stocking the combined company's development pipeline with cancer, immunology and cardiovascular treatments. Bristol would gain the cancer treatment Revlimid in the cash-and-stock deal announced...
Source: ABC - 🏆 471. / 51 Read more »
Bristol-Myers Squibb looks to swallow CelgeneThe $90bn merger would be one of the biggest pharmaceutical deals in history Deals like these make generic production much more difficult, including for Revlimid. This is the result of letting pharma be dominated by MBAs instead of MDs.
Source: TheEconomist - 🏆 6. / 92 Read more »
Bristol-Myers Squibb shares pop on report Starboard Value has taken a stake in drugmakerThe size of the stake and plans that the activist hedge fund might have for its investment couldn't be immediately learned, according to Bloomberg.
Source: CNBC - 🏆 12. / 72 Read more »